GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Rochester
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute